Doctors vote in favour of continuing industrial action

Resident doctors in England have voted to continue industrial action for six months after a ballot with 53% turnout and 93% voting in favour, extending a dispute that has already produced 14 strikes since 2023. The BMA says a new jobs package and multi-year pay offer could be negotiated, while the government, citing a 28.9% pay rise over three years, says it cannot go further on pay; NHS leaders warn further strikes will add unplanned costs, strain services and force difficult budgetary choices. The outcome raises operational and fiscal pressure on NHS providers and keeps the prospect of disruptive, cost-adding industrial action on the table, though it is unlikely to be a major market-moving event.

Analysis

Market structure: Continued resident doctor strikes materially raise near-term marginal demand for private elective care and locum staffing while depressing NHS throughput and increasing unplanned NHS costs. Expect private hospital chains and recruitment/locum firms to pick up 5–10% of elective volume over 3–12 months if strikes recur, improving short-term pricing power for private operators but squeezing NHS budgets and capital spending.

Risk assessment: Tail risks include a protracted strike cycle forcing a government pay settlement that costs >£1bn–£3bn and pushes 10y gilt yields +20–50bps, or political escalation ahead of elections materially worsening fiscal premium on UK assets. Immediate impact will show up in days (cancellations), weeks–months in private sector revenues and staffing hire spikes, and quarters–years in fiscal balance and doctor supply if legislation changes training/visa rules.

Trade implications: Tactical long exposure to UK private healthcare and staffing, paired with hedges against sterling and gilts, is attractive; small-cap domestic cyclicals and hospital trusts are first-order losers. Use short-dated options to express short-tail risk (strike-based FX puts, gilt-duration shorts) while using directional equity positions with 10–15% take-profit bands given binary negotiation outcomes.

Contrarian angles: Consensus focuses on NHS pain but underprices persistent revenue transfer to private providers and staffing agencies; conversely, if a mediated deal arrives within 30–60 days, private names will mean-revert. Historical strikes produced short-lived dislocations — prefer option structures (put buying, call spreads) to capture asymmetry rather than large outright exposures.

Key Decisions for Investors

• Establish a 2–3% portfolio long in Spire Healthcare (LSE: SPI.L) sized to 2–3% of NAV with a 3–12 month horizon to capture a 5–10% elective volume shift; set stop-loss at -12% and trim 50% at +15% or if BMA and Government announce a mediated settlement within 30 days.
• Establish a 1.5–2% long in Hays plc (LSE: HAS.L) to play elevated locum/recruitment demand over the next 1–6 months; scale in on pullbacks >5% and exit if quarterly guidance shows temporary staffing revenue contraction >5% QoQ.
• Hedge UK/domestic risk by buying 3-month GBP/USD puts (cost notional ≈0.5% portfolio) with strike ~2% below spot or short 1–2% notional of EWU (iShares MSCI United Kingdom ETF) to protect against a >2–3% GBP move or gilt-driven risk-off; take-profit if GBP falls 3% or unwind if a negotiated deal is signed within 14–30 days.
• Buy 3-month protective puts on a UK domestic ETF (e.g., EWU) equal to 0.5–1% notional as tail insurance; monetize by selling a small number of out-of-the-money calls on private healthcare names to finance part of the premium if conviction in private upside is strong.